24 completed, 3 terminated, 1 withdrawn. 28 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 28 | Completed 24, Terminated 3, Withdrawn 1 |
Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART) nelfinavir, lopinavir/r, indinavir - HIV Infections | Not applicable | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 115 | 2002-07-01 | 2005-08-01 |
| Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women Indinavir sulfate, Ritonavir, Nelfinavir mesylate - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 76 | 2001-06-01 | 2012-11-02 |
| Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers Indinavir sulfate, Ritonavir, Amprenavir - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 90 | 2001-03-01 | 2021-11-01 |
| Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir Indinavir sulfate, Ritonavir, Delavirdine mesylate - HIV Infections | Not applicable | Terminated | Agouron Pharmaceuticals | 60 | 2000-08-01 | 2005-06-24 |
| Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV Tetanus Toxoid Vaccine, Indinavir sulfate, Lamivudine/Zidovudine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 288 | 1999-10-01 | 2011-03-02 |
| Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection Indinavir sulfate, Diphenhydramine hydrochloride, Lymphocytes, Activated - HIV Infections | Not applicable | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 16 | 2016-12-14 | |
| A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC Indinavir sulfate, Lamivudine, Zidovudine - HIV Infections | Not applicable | Completed | Merck Sharp & Dohme LLC | 600 | 2005-06-24 | |
| A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Not applicable | Completed | Bristol-Myers Squibb | 200 | 2007-10-02 | |
| A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients Indinavir sulfate, Delavirdine mesylate, Lamivudine - HIV Infections | Not applicable | Completed | Pharmacia and Upjohn | 160 | 2005-06-24 | |
| A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 Indinavir sulfate, Ritonavir, Nelfinavir mesylate - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1300 | 2021-10-29 | |
| A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks Indinavir sulfate, Ritonavir, Nelfinavir mesylate - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 800 | 2021-10-29 | |
| A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients Indinavir sulfate, Delavirdine mesylate, Zidovudine - HIV Infections | Not applicable | Completed | Pharmacia and Upjohn | 32 | 2005-06-24 | |
| A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Not applicable | Completed | Bristol-Myers Squibb | 200 | 2007-10-02 | |
| The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients Indinavir sulfate - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1900 | 2021-10-28 | |
| A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection Indinavir sulfate, Lamivudine/Zidovudine, Ritonavir - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 900 | 2012-06-07 | |
| A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) Indinavir sulfate, Abacavir sulfate, Nelfinavir mesylate - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1710 | 2014-04-17 | |
| The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz Indinavir sulfate, Efavirenz - HIV Infections | Not applicable | Completed | Merck Sharp & Dohme LLC | 80 | 2005-06-24 | |
| A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) Indinavir sulfate - HIV Infections | Not applicable | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-14 | ||
| Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection Indinavir sulfate, Nelfinavir mesylate, Lamivudine - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2011-03-02 | |
| A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients Indinavir sulfate, Stavudine - HIV Infections | Not applicable | Completed | Merck Sharp & Dohme LLC | 540 | 2005-06-24 |
Showing 20 of 28. Sign in to see all of them.
HIV Infections (28) · Acquired Immunodeficiency Syndrome (4) · AIDS-Related Complex (1) · Adolescent Behavior (1) · Disease Progression (1) · Hepatitis B (1) · Tetanus (1)
National Institute of Allergy and Infectious Diseases (NIAID) (13) · Merck Sharp & Dohme LLC (6) · Pharmacia and Upjohn (3) · Bristol-Myers Squibb (2) · Abbott (1) · Agouron Pharmaceuticals (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Weill Medical College of Cornell University (1)
United States (25) · Puerto Rico (4) · Australia (1) · Canada (1) · France (1) · Italy (1)
Crane L (1) · David Ho (1) · Dominique Salmon, MD (1) · France Mentre, MD (1) · Gene Morse (1) · Gregory Robbins (1) · Jay R. Kostman (1) · Lawrence Corey (1) · Lawrence R. Crane (1) · MacArthur R (1) · Mayers D (1) · Perez G (1) · Rhonda G. Kost (1) · Richard Novak, MD (1) · Richard Pollard (1)
PMID 11306155, PMID 14668455, PMID 14668456, PMID 15002082, PMID 15187476, PMID 16048950, PMID 16048984, PMID 16103764, PMID 16192247, PMID 16267764, PMID 16810109, PMID 16816555, PMID 17174704, PMID 17662759, PMID 18176329, PMID 18226670, PMID 18977721, PMID 20467286, PMID 20687947, PMID 24326304, PMID 33901188